Draft:CanTEST

• Comment: Well done on creating the draft, and it may potentially meet the relevant requirements (including WP:GNG, WP:NCORP) but presently it is not clear that it does.
  As you may know, Wikipedia's basic requirement for entry is that the subject is notable. Essentially subjects are presumed notable if they have received significant coverage in multiple published secondary sources that are reliable, intellectually independent of each other, and independent of the subject. To properly create such a draft page, please see the articles ‘Your First Article’, ‘Referencing for Beginners’ and ‘Easier Referencing for Beginners’.
  Please note that many of the references are not from sources that are considered reliable for establishing notability and should be removed (including blogs, company websites, Twitter, YouTube, Instagram, Spotify etc).
  Please remove links from words that do not contain actual Wikipedia links (the text in red).
  The draft does not appear to show that the subject has any notability beyond the average coverage in trade publications for similar organisations (see WP:ROTM).
  Also, if you have any connection to the subject, including being paid, you have a conflict of interest that you must declare on your Talk page (to see instructions on how to do this please click the link).
  Please familiarise yourself with these pages before amending the draft. If you feel you can meet these requirements, then please make the necessary amendments before resubmitting the page. It would help our volunteer reviewers by identifying, on the draft's talk page, the WP:THREE best sources that establish notability of the subject.
  It would also be helpful if you could please identify with specificity, exactly which criteria you believe the page meets (eg "I think the page now meets WP:NCORP criteria #3, because XXXXX").
  Once you have implemented these suggestions, you may also wish to leave a note for me on my talk page and I would be happy to reassess. Cabrils (talk) 04:32, 8 October 2024 (UTC)

---

CanTEST Health and Drug Checking Service

CanTEST Health and Drug Checking Service is the first fixed-site drug checking service in Australia, based in Canberra, Australian Capital Territory (ACT). Launched in 2022, CanTEST provides a harm reduction service that allows individuals to anonymously submit samples of illicit substances for testing, while also offering health advice and drug-related education. The initiative aims to reduce the harm associated with drug use, including drug-related overdoses and adverse effects from unknown contaminants.

The service is operated by Directions Health Services in collaboration with the Australian National University (ANU), ACT Health, and the Canberra Alliance for Harm Minimisation and Advocacy (CAHMA). CanTEST marks a significant step forward in harm reduction strategies within Australia, providing a safe and non-judgmental space for people who use drugs to better understand the substances they are taking.

History and Establishment

CanTEST was launched in July 2022 as a six-month pilot project but has since been extended due to its success and positive impact on public health. The service was created in response to growing concerns over the high incidence of drug overdoses and drug-related deaths in Australia, particularly those involving synthetic opioids and other dangerous adulterants. The pilot was modeled on successful drug checking services in countries like New Zealand, the Netherlands, and parts of Europe, where similar services have demonstrated reductions in drug-related harm.

The service is designed to be a harm reduction tool, providing information on the purity and composition of recreational drugs, allowing individuals to make informed decisions about drug use. CanTEST has also contributed to broader efforts to track the presence of dangerous substances in the community, issuing warnings and alerts when toxic substances are detected.

Services and Process

At CanTEST, users can submit small samples of drugs for testing. Substances commonly tested include MDMA, cocaine, ketamine, LSD, and other psychoactive substances. The testing process uses advanced techniques such as Fourier-transform infrared spectroscopy (FTIR) and ultraviolet-visible spectrophotometry to identify the chemical components of the substances. These methods provide results quickly, typically within 30 minutes.

Alongside drug testing, CanTEST also offers health consultations where individuals can receive advice on how to reduce the risks associated with drug use, including safer consumption practices. The service operates with a focus on confidentiality, ensuring that participants can access the service without fear of legal repercussions or stigma.

In addition to individual test results, CanTEST aggregates data on the substances tested and provides this information to public health authorities to help monitor emerging trends in drug use and identify potential threats from new or dangerous substances in the local drug market.

Impact and Results

Since its inception, CanTEST has been well-received, with hundreds of individuals using the service during its pilot phase. It has been credited with helping to prevent potentially fatal overdoses by identifying dangerous substances, including synthetic opioids and highly potent MDMA pills. The service has also helped raise awareness of drug safety and harm reduction strategies among the general public, particularly within the Canberra community.

Early reports from the ACT Government and health services indicate that the program has contributed to a significant reduction in drug-related incidents at festivals and in nightlife settings where drug use is common. The public health data collected by CanTEST is being used to inform policy decisions around drug use and harm reduction in the ACT and potentially across Australia.

Collaborations

CanTEST operates in partnership with several key organizations:

• Directions Health Services: Provides healthcare services and manages the operation of CanTEST.
• Australian National University (ANU): Conducts research related to drug use, harm reduction, and drug-checking practices. ANU researchers collaborate with CanTEST to analyze the data collected from drug testing and study its impact on public health.
• ACT Health: Provides governmental support and ensures that CanTEST operates within the framework of the ACT’s health policies.
• Canberra Alliance for Harm Minimisation and Advocacy (CAHMA): A grassroots organization that advocates for the rights and safety of people who use drugs. CAHMA plays an important role in community outreach and educating the public about drug safety.

Reception and Expansion

CanTEST has been recognized as a pioneering harm reduction initiative in Australia and is being closely watched as a potential model for similar services in other states. Many harm reduction advocates have called for drug-checking services like CanTEST to be implemented nationwide as part of a broader strategy to address Australia’s opioid crisis and prevent drug-related harm.

As of 2023, the ACT Government has committed to extending the CanTEST pilot, and discussions are underway to make the service a permanent fixture in Canberra’s public health system. The expansion of CanTEST has also sparked conversations about drug decriminalization and further harm reduction measures in other parts of Australia.

Challenges and Criticism

While CanTEST has been praised for its harm reduction efforts, it has faced some criticism from those who argue that drug-checking services may implicitly encourage drug use by providing a false sense of security. Proponents of the service, however, maintain that drug checking does not condone or promote drug use, but instead offers potentially life-saving information to those who choose to use drugs.

Another challenge has been ensuring that the service is accessible to all members of the community, particularly those who may be hesitant to engage with drug-related services due to legal concerns or social stigma. However, CanTEST has taken steps to maintain strict confidentiality and anonymity to encourage participation.

See Also

• Drug checking
• Harm reduction
• Opioid crisis in Australia
• Drug policy reform in Australia

External Links

• CanTEST Health and Drug Checking Service - Official Website
• ACT Health - CanTEST Service